J&J Aiming to Produce 1 Million Doses of Ebola Vaccine in 2015

Janssen, a unit of J&J, plans to produce more than one million doses of the vaccine regimen in 2015, and 250,000 of them are expected to be released for broad application in clinical trials by next May. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.